@FiercePharma: Pfizer shuttering vitamin C plant in California, 70 workers out of jobs. FiercePharmaManufacturing story | Follow @FiercePharma
@EricPFierce: UK starts on $85M cell manufacturing facility as report shows country has become net importer of drugs. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Merck's Rebif held its own in last year's MS market shakeup. What about 2015? More | Follow @CarlyHFierce
> The controlling shareholder in allergy drug specialist Stallergenes has proposed merging with its U.S. partner Greer to create a company with combined sales of €330 million, or about $368 million. Report
> The Polish drug market grew to €6.5 billion in 2014, with almost half of that spent on over-the-counter remedies. Report
> India's Sun Pharma bought GlaxoSmithKline's ($GSK) opiates business in Australia, a move that put Sun in charge of a quarter of the world's opiate supply, derived from poppies grown in the states of Tasmania and Victoria. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Nevro appoints former JJDC head to board as it awaits anticipated FDA approval. Article | Follow @FierceMedDev
@VarunSaxena2: FDA requires new labeling on insulin pens to ward off spread of infections. More from FierceDrugDelivery | Follow @VarunSaxena2
@EmilyWFierce: Pharma CMO? Meet your CIO--and start working together already. FiercePharmaMarketing article | Follow @EmilyWFierce
> Studies show need to supplement mammography with MRI, ultrasound for dense breast tissue. News
> Intuitive Surgical returns to the battlefield with $430M DOD contract. Article
> S&N falls on Stryker buyback plan, buys into Latin American distributor. Story
Biotech News
@FierceBiotech: Scripps investigators ID a key player in disarming chemotherapy. FierceBiotechResearch story | Follow @FierceBiotech
@JohnCFierce: Bristol-Myers forges a billion-dollar cancer vaccine deal with Bavarian Nordic. News | Follow @JohnCFierce
@DamianFierce: Alkahest, a @JNJInnovation incuabatee, signed a $50M deal with Grifols. Release | Follow @DamianFierce
> Warp Drive recruits an Alnylam vet to take the reins. Item
> As split looms, Baxter bags autoimmune biotech SuppreMol for $225M. Story
> Startup Alkahest inks a $50M deal for anti-aging R&D. Article
> Genfit is next up in the M&A rumor mill thanks to its NASH drug. Report
Drug Delivery News
> Chrono Therapeutics ropes in new funds from Rock Health for smoking cessation device. Story
> Forbes gives drug delivery a shoutout, says it can make good drugs great. Item
> FDA requires new labeling on insulin pens to ward off spread of infections. Article
> Amgen launches delivery device for automatic administration of its blockbuster Neulasta. News
> Evidence that inhaled oxytocin improves social behavior among autistic patients spurs R&D. More
Diagnostics News
> FDA grants emergency use authorization to Corgenix's fast-acting Ebola diagnostic. Article
> RainDance waltzes toward $60M IPO. News
> Skin test could vastly simplify diagnosis of Alzheimer's and Parkinson's. More
> Exact Sciences beefs up sales and reimbursement efforts for colon cancer Dx. Story
> Vigilant Biosciences reels in $5.5M for oral cancer test. Report
Pharma Marketing News
> The long, strange story of Cubist's Cards Against Biotechnology. Feature
> Goldman cuts Afrezza sales forecast in half on slow uptake, pricing pressure. Report
> Surprise: Obesity med Contrave might help CV outcomes. Too bad Orexigen blabbed it. More
> The PD-1 wave? Report says it's a $33B tsunami, with BMS surfing for first place. Story
> Pharma CMO? Meet your CIO--and start working together already. Article
And Finally... Elderly people with cognitive problems may suffer faster decline if their blood pressure is too tightly controlled with drugs. Report